Form 8-K - Current report:
SEC Accession No. 0001558370-19-011410
Filing Date
2019-12-06
Accepted
2019-12-06 16:03:24
Documents
2
Period of Report
2019-12-06
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K f8-k.htm 8-K 92096
2 EX-99.1 ex-99d1.htm EX-99.1 11386
  Complete submission text file 0001558370-19-011410.txt   104606
Mailing Address P.O. BOX 130235 ANN ARBOR MI 48113
Business Address P.O. BOX 130235 ANN ARBOR MI 48113 734-245-1700
Gemphire Therapeutics Inc. (Filer) CIK: 0001638287 (see all company filings)

EIN.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37809 | Film No.: 191273126
SIC: 2834 Pharmaceutical Preparations